Hyperflav - Perspective photosensitizer for PDT: Cell studies

Experimental Oncology

Volumn 32, Issue 4, 2010, Pages 233-236

  Yermak, P V ^a   Gamaleia, N F ^a   Shalamay, A S ^b   Saienko, T V ^b   Kholin, V V ^c  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b SIC Borshchahivskiy Chemical Pharmaceutical Plant CJSC   (Ukraine)

^c SME Photonika Plus   (Ukraine)

Author keywords

Antitumor effect; Gold nanoparticles; Hypericin; Hypericum extract; Photodynamic therapy (PDT)

Indexed keywords

ALCOHOL; GOLD NANOPARTICLE; HYPERFLAV; HYPERICUM EXTRACT; PHOTOSENSITIZING AGENT; POVIDONE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CELL DEATH; CELL STRAIN; CELL STRAIN MT 4; CONTROLLED STUDY; DRUG EFFICACY; DRUG SOLUBILITY; FLUORESCENCE; IN VITRO STUDY; IRRADIATION; LEUKEMIA CELL; LEUKEMIA CELL LINE; NAMALWA CELL; PHOTOTOXICITY; RADIATION DOSE; SPECTROSCOPY;

HUMANS; HYPERICUM; JURKAT CELLS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PLANT EXTRACTS;

EID: 78650698067     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Robertson CA, Hawkins Evans D, Abrahamse H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B: Biology 2009; 96: 1-8.
2. Schmitt LA, Liu Y, Murphy PA, et al. Reduction in hypericin-induced phototoxicity by Hypericum perforatum extracts and pure compounds. J Photochem Photobiol B: Biology 2006; 85: 118-30.
3. Miller AL. St. John's wort (Hypericum perforatum): clinical effects on depression and other conditions. Alternative Med Rev 1998; 3: 18-26.
4. Jacobson JM, Feinman L, Liebes L, et al. Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother 2001; 45: 517-24.
5. Lavie G, Mazur Y, Lavie D, et al. Hypericin as an inactivator of infectious viruses in blood components. Transfusion 1995; 35: 392-400.
6. Machado RAF, Casella AMB, Malaguido MR, et al. Experimental study of vitreoretinal proliferation inhibition by the use of hypericin. Arq Bras Oftalmol 2009; 72: 650-4.
7. Kamuhabwa A, Agostinis P, Ahmed B, et al. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder. Photochem Photobiol Sci 2004; 3: 772-80.
8. Besic E, Forny P, Lüscher D, et al. Photodynamic effects of hypericin and Foslipos in head and neck squamous cell carcinoma in vitro. Congress Abstracts/Medical Laser Application 2009; 24: 136-7.
9. Miccoli L, Beurdeley-Thomas A, De Pinieux G, et al. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res 1998; 58: 5777-86.
10. Rück A, Pfaffel-Schubart G, Hauser C, et al. Hypericin as potential PDT drug to treat glioblastoma. Congress Abstracts/Medical Laser Application 2009; 24: 136.
11. Jocham D, Stepp H, Waidelich R. Photodynamic diagnosis in urology: state-of-the-art. Eur Urology 2008; 53: 1138-50.
12. Agostinis P, Vantieghema A, Merlevede W. Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 2002; 34: 221-41.
13. Yamazaki T, Ohta N, Yamazaki I, et al. Excited-state properties of hypericin: electronic spectra and fluorescence decay kinetics. J Phys Chem 1993, 97: 7870-75.
14. Huygens A, Kamuhabwa AR, de Witte PAM. Stability of different formulations and ion pairs of hypericin. Eur J Pharm Biopharm 2005; 59: 461-68.
15. Chen B, Xu Y, Roskams T, et al. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer 2001; 93: 275-82.
16. Cai W, Gao T, Hong H, et al. Applications of gold nanoparticles in cancer nanotechnology. Nanotech Sci Applications 2008; 1: 17-32.
17. Gamaleia N, Shishko E, Dolinsky G, et al. Photodynamic activity of hematoporphyrin conjugates with gold nanoparticles: experiments in vitro. Exp Oncol 2010, 32: 44-7.
18. Skalkos D, Gioti E, Stalikas CD, et al. Photophysical properties of Hypericum perforatum L. extracts - novel photosensitizers for PDT. J Photochem Photobiol B: Biology 2006; 82: 146-51.
19. Stavropoulos NE, Kim A, Nseyo UU, et al. Hypericum perforatum L. extract - novel photosensitizer against human bladder cancer cells. J Photochem Photobiol B: Biology 2006; 84: 64-9.
20. Saw CL, Olivo M, Soo KC, et al. Spectroscopic characterization and photobleaching kinetics of hypericin-N-methyl pyrrolidone formulations. Photochem Photobiol Sci 2006; 5: 1018-23.
21. Kubin A, Loew HG, Burner U, et al. How to make hypericin water-soluble. Pharmazie 2008; 63: 263-9.
22. Saw CL, Olivo M, Soo KC, et al. Delivery of hypericin for photodynamic applications. Cancer Letters 2006; 241: 23-30.
23. Besic E, Wirth A, Maake C, et al. Uptake and distribution of hypericin doped silica nanoparticles in human cancer cells for future therapy. EPPM-1 Abstr Photodiag and Photodyn Ther 2008; 5: 74.
24. Mirossay A, Onderkova H, Mirossay L, et al. The effect of quercetin on light-induced cytotoxicity of hypericin. Physiol 2001; 50: 635-7.